Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lymphoma × Quality of Life × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 To Observe Whether the Fucoidan Can Improve the Quality of Life of the Such Patients Receiving the Neoadjuvant CCRT 1 Symptom Management 1 Sexual Dysfunction, Physiological 1 Rectal Neoplasms 1 Quality of Life 1 Lymphoma 1 Hematologic Neoplasms 1 Ascites 1

Interventions

Cyclophosphamide 33 Vincristine 23 Etoposide 21 Cytarabine 19 Radiotherapy 17 Doxorubicin 17 Rituximab 16 Melphalan 16 Peripheral Blood Stem Cell Transplantation 14 Prednisolone 13 Filgrastim 13 Methotrexate 12 fludarabine phosphate 11 Prednisone 11 Dexamethasone 9 Carmustine 9 Bleomycin 9 Cyclosporine 8 Busulfan 8 Ifosfamide 7 Cisplatin 7 Vinblastine 6 Gemcitabine 6 Antilymphocyte Serum 6 sargramostim 5 pegylated granulocyte colony-stimulating factor 5 fludarabine 5 Mitoxantrone 5 Methylprednisolone 5 Chlorambucil 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04187118 2023-09-21

QUALIPSO-L

University Hospital, Toulouse

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡